Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70087 ↗At a glance
Übersichtsarbeit in Chemical Biology & Drug Design, 2025. Written by Yu Jiang and 4 co-authors. Institution: West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China. Major MEDLINE topics: Protein Kinase Inhibitors, Small Molecule Libraries. Cited 5 times so far (Crossref); 57 references.
Abstract (original language)
Cdc2‐like kinase 4 (Clk4), a key member of the CMGC kinase family, plays a crucial role in alternative splicing, which profoundly influences various physiological processes, including cellular signaling, proliferation, and survival. Its involvement in these vital functions has positioned Clk4 as an important target for therapeutic intervention in a range of diseases, such as neurodegenerative disorders, viral and parasitic infections, and cancer. This review highlights recent advancements in Clk4 inhibitors, covering both natural, and synthetic compounds. It further examines the core scaffolds and essential functional groups of Clk4 small‐molecule inhibitors, emphasizing the most promising chemical structures. Additionally, the review explores the structure–activity relationships (SARs) and molecular binding modes of existing Clk4 inhibitors, offering insights and strategies for the development of novel Clk4‐targeted drugs. This review highlights recent advancements in small molecule inhibitors targeting Clk4, emphasizing their potential in treating cancers and neurodegenerative diseases. It explores SARs, binding modes, and challenges in developing selective Clk4 inhibitors, offering insights for future therapeutic strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.
- Pediatric Otolaryngology Head and Neck Surgery, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan Univ…
- Department of Orthodontics, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
ORCID profiles: Jing Wang
Cite
APA
Jiang, Y., Tang, Z., Jiang, M., Wang, J., & Wang, Y. (2025). Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70087
Vancouver
Jiang Y, Tang Z, Jiang M, Wang J, Wang Y. Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70087
BibTeX
@article{Jiang2025,
author = {Jiang, Yu and Tang, Zihua and Jiang, Minggao and Wang, Jing and Wang, Yanhai},
title = {Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70087}
}
EUVIMED